141 related articles for article (PubMed ID: 38683728)
1. Acute Promyelocytic Leukemia.
Winkler C
N Engl J Med; 2024 May; 390(17):e42. PubMed ID: 38683728
[No Abstract] [Full Text] [Related]
2. Switching from all-trans retinoic acid to arsenic trioxide for newly diagnosed acute promyelocytic leukemia.
Imagawa J
Leuk Lymphoma; 2018 Dec; 59(12):3013-3015. PubMed ID: 29616847
[No Abstract] [Full Text] [Related]
3. JSH practical guidelines for hematological malignancies, 2018: I. Leukemia-2. Acute promyelocytic leukemia (APL).
Fujita H; Ishikawa Y; Yokoyama Y
Int J Hematol; 2020 Jun; 111(6):747-760. PubMed ID: 32347422
[No Abstract] [Full Text] [Related]
4. Bone Marrow Findings in Patients With Acute Promyelocytic Leukemia Treated With Arsenic Trioxide.
Miller KP; Venkataraman G; Gocke CD; Batista DA; Borowitz MJ; Burns KH; Pratz K; Duffield AS
Am J Clin Pathol; 2019 Oct; 152(5):675-685. PubMed ID: 31305869
[TBL] [Abstract][Full Text] [Related]
5. Recurrent acute myopericarditis without effusion during ATRA induction and ATO salvage of APL: a variant form of the differentiation syndrome?
Vassilakopoulos TP; Asimakopoulos JV; Plata E; Kelepesis G; Petevi K; Koutsi C; Papageorgiou L; Tsaftaridis P; Angelopoulou MK; Konstantopoulos K; Meletis J
Leuk Lymphoma; 2017 Jul; 58(7):1743-1746. PubMed ID: 27919176
[No Abstract] [Full Text] [Related]
6. Long-term prognosis of childhood acute promyelocytic leukaemia with arsenic trioxide administration in induction and consolidation chemotherapy phases: a single-centre experience.
Cheng Y; Zhang L; Wu J; Lu A; Wang B; Liu G
Eur J Haematol; 2013 Dec; 91(6):483-9. PubMed ID: 24033687
[TBL] [Abstract][Full Text] [Related]
7. Does acute promyelocytic leukemia patient with the STAT5B/RARa fusion gene respond well to decitabine?: A case report and literature review.
Wang L; Yan X; He J
Medicine (Baltimore); 2020 Oct; 99(43):e22923. PubMed ID: 33120845
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
Lo-Coco F; Avvisati G; Vignetti M; Thiede C; Orlando SM; Iacobelli S; Ferrara F; Fazi P; Cicconi L; Di Bona E; Specchia G; Sica S; Divona M; Levis A; Fiedler W; Cerqui E; Breccia M; Fioritoni G; Salih HR; Cazzola M; Melillo L; Carella AM; Brandts CH; Morra E; von Lilienfeld-Toal M; Hertenstein B; Wattad M; Lübbert M; Hänel M; Schmitz N; Link H; Kropp MG; Rambaldi A; La Nasa G; Luppi M; Ciceri F; Finizio O; Venditti A; Fabbiano F; Döhner K; Sauer M; Ganser A; Amadori S; Mandelli F; Döhner H; Ehninger G; Schlenk RF; Platzbecker U; ; ;
N Engl J Med; 2013 Jul; 369(2):111-21. PubMed ID: 23841729
[TBL] [Abstract][Full Text] [Related]
9. Guest editorial: acute promyelocytic leukemia: change from "highly fatal to highly curable" leukemia.
Komatsu N
Int J Hematol; 2014 Jul; 100(1):16-7. PubMed ID: 24912657
[No Abstract] [Full Text] [Related]
10. Acute promyelocytic leukemia in a patient with chronic lymphocytic leukemia-A case report.
Boddu P; Schlette E; Thakral B; Tang G; Pemmaraju N; Kadia T; Ferrajoli A; Ravandi F; Wierda W; Jain N
Hematol Oncol Stem Cell Ther; 2019 Sep; 12(3):161-165. PubMed ID: 28830803
[TBL] [Abstract][Full Text] [Related]
11. PML-RARA transcript levels at the end of induction therapy are associated with prognosis in non-high-risk acute promyelocytic leukaemia with all-trans retinoic acid plus arsenic in front-line therapy: long-term follow-up of a single-centre cohort study.
Tang FF; Lu SY; Zhao XS; Qin YZ; Liu XH; Jia JS; Wang J; Gong LZ; Jiang Q; Zhao T; Shi HX; Chang YJ; Huang XJ; Jiang H
Br J Haematol; 2021 Dec; 195(5):722-730. PubMed ID: 34405393
[TBL] [Abstract][Full Text] [Related]
12. First report of successful management of acute promyelocytic leukemia in a pregnant female with All-Trans-Retinoic Acid and Arsenic Trioxide-based induction regimen.
Khosla H; Jain A; Tatawadiya S; Prasad P; Nagpal K; Chaudhry S; Sharma M; Gupta DK; Saluja S; Jain A
Blood Cells Mol Dis; 2020 Nov; 85():102476. PubMed ID: 32688220
[No Abstract] [Full Text] [Related]
13. Flexural Eruption Associated With Arsenic Trioxide Therapy in a Patient With Acute Promyelocytic Leukemia.
Teran VA; Wilson BB; Guffey DJ
JAMA Dermatol; 2019 Mar; 155(3):389-391. PubMed ID: 30673070
[No Abstract] [Full Text] [Related]
14. Retinoic acid syndrome induced by arsenic trioxide in treating recurrent all-trans retinoic acid resistant acute promyelocytic leukemia.
Che-Pin Lin ; Huang MJ; Chang IY; Lin WY; Sheu YT
Leuk Lymphoma; 2000 Jun; 38(1-2):195-8. PubMed ID: 10811463
[TBL] [Abstract][Full Text] [Related]
15. Molecular remission without blood product support using all-trans retinoic acid (ATRA) induction and combined arsenic trioxide/ATRA consolidation in a Jehovah's Witness with de novo acute promyelocytic leukaemia.
Kennedy GA; Marlton P; Cobcroft R; Gill D
Br J Haematol; 2000 Dec; 111(4):1103-5. PubMed ID: 11167746
[TBL] [Abstract][Full Text] [Related]
16. Microgranular variant of acute promyelocytic leukemia with cytoplasmic projections resembling micromegakaryocytes.
Jiang W; Lee SH
Blood; 2018 Nov; 132(21):2314. PubMed ID: 30467190
[No Abstract] [Full Text] [Related]
17. Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia.
Breccia M; Foà R
Expert Rev Hematol; 2019 Feb; 12(2):81-87. PubMed ID: 30572725
[TBL] [Abstract][Full Text] [Related]
18. [All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis].
Nagao R; Hosoba R; Yahagi Y; Gunji T; Uryu H; Hattori D; Momoki M; Yamazaki H
Rinsho Ketsueki; 2019; 60(10):1431-1435. PubMed ID: 31695003
[TBL] [Abstract][Full Text] [Related]
19. Acute promyelocytic leukemia with myelofibrosis: A case report and literature review.
Xiao M; Qin L; Niu X; Zhou P; Niu J; Wei S; Li D; Dou L; Zhang W; Zhang L; Sun K; Bai Y
Medicine (Baltimore); 2021 Apr; 100(13):e24567. PubMed ID: 33787572
[TBL] [Abstract][Full Text] [Related]
20. Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia.
Fabiani E; Cicconi L; Nardozza AM; Cristiano A; Rossi M; Ottone T; Falconi G; Divona M; Testi AM; Annibali O; Castelli R; Lazarevic V; Rego E; Montesinos P; Esteve J; Venditti A; Della Porta M; Arcese W; Lo-Coco F; Voso MT
Cancer Med; 2021 Jun; 10(12):3839-3847. PubMed ID: 34042280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
